BlueCrest Capital Management’s West Pharmaceutical WST Stock Holding History

BlueCrest Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,720	Closed	-$244K	–	611
2019 Q3	$244K	Buy	+1,720	New	+$237K	0.02%	437
2018 Q2	–	Sell	-19,303	Closed	-$1.7M	–	1855
2018 Q1	$1.7M	Buy	+19,303	New	+$1.81M	0.05%	329
2017 Q4	–	Sell	-2,362	Closed	-$227K	–	1135
2017 Q3	$227K	Buy	+2,362	New	+$214K	0.01%	722
2017 Q1	–	Sell	-3,299	Closed	-$280K	–	980
2016 Q4	$280K	Buy	+3,299	New	+$259K	0.02%	560
2016 Q3	–	Sell	-6,358	Closed	-$482K	–	1018
2016 Q2	$482K	Buy	+6,358	New	+$463K	0.02%	536
2015 Q4	–	Sell	-4,759	Closed	-$258K	–	1204
2015 Q3	$258K	Buy	+4,759	New	+$277K	0.01%	738

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

BlueCrest Capital Management's WST Position: Q4 2019 in Review

BlueCrest Capital Management sold out of West Pharmaceutical (WST) in Q4 2019, closing a stake of 1,720 shares — an estimated $244K sold.

BlueCrest Capital Management first reported a position in WST in Q3 2015 and held it in 6 quarters. The position peaked at $1.7M in Q1 2018. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

BlueCrest Capital Management reported no remaining West Pharmaceutical position as of Q4 2019 after selling out during the quarter.
BlueCrest Capital Management sold 1,720 West Pharmaceutical shares in Q4 2019, an estimated $244K.
BlueCrest Capital Management first reported a position in West Pharmaceutical in Q3 2015 and held it in 6 quarters.
BlueCrest Capital Management's West Pharmaceutical position peaked at $1.7M in Q1 2018.
445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.